361 related articles for article (PubMed ID: 30055692)
1. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2.
Wielders LHP; Schouten JSAG; Winkens B; van den Biggelaar FJHM; Veldhuizen CA; Murta JCN; Goslings WRO; Kohnen T; Tassignon MJ; Joosse MV; Henry YP; Nagy ZZ; Rulo AHF; Findl O; Amon M; Nuijts RMMA;
J Cataract Refract Surg; 2018 Jul; 44(7):836-847. PubMed ID: 30055692
[TBL] [Abstract][Full Text] [Related]
2. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.
Wielders LHP; Schouten JSAG; Winkens B; van den Biggelaar FJHM; Veldhuizen CA; Findl O; Murta JCN; Goslings WRO; Tassignon MJ; Joosse MV; Henry YP; Rulo AHF; Güell JL; Amon M; Kohnen T; Nuijts RMMA;
J Cataract Refract Surg; 2018 Apr; 44(4):429-439. PubMed ID: 29778106
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
4. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
[TBL] [Abstract][Full Text] [Related]
5. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
Lim LL; Morrison JL; Constantinou M; Rogers S; Sandhu SS; Wickremasinghe SS; Kawasaki R; Al-Qureshi S
Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of prevention of cystoid macular edema after cataract surgery in diabetic patients: ESCRS PREMED study report 6.
Simons RWP; Wielders LHP; Nuijts RMMA; Veldhuizen CA; van den Biggelaar FJHM; Winkens B; Schouten JSAG; Dirksen CD;
J Cataract Refract Surg; 2022 May; 48(5):555-563. PubMed ID: 34417781
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C; Salsini G; Perri P
Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification.
Ahmadabadi HF; Mohammadi M; Beheshtnejad H; Mirshahi A
J Cataract Refract Surg; 2010 Jun; 36(6):917-22. PubMed ID: 20494761
[TBL] [Abstract][Full Text] [Related]
10. Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One Year.
Mylonas G; Schranz M; Scholda C; Karst S; Reiter G; Baumann L; Schmidt-Erfurth U; Kriechbaum K
Curr Eye Res; 2020 Sep; 45(9):1107-1113. PubMed ID: 31961224
[TBL] [Abstract][Full Text] [Related]
11. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
13. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Warren KA; Bahrani H; Fox JE
Retina; 2010 Feb; 30(2):260-6. PubMed ID: 20175270
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results.
Kandasamy R; Constantinou M; Rogers SL; Sandhu SS; Wickremasinghe S; Al-Qureshi S; Lim LL
Br J Ophthalmol; 2019 Dec; 103(12):1753-1758. PubMed ID: 30819688
[TBL] [Abstract][Full Text] [Related]
15. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
Kim SY; Yang J; Lee YC; Park YH
J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy.
Chae JB; Joe SG; Yang SJ; Lee JY; Sung KR; Kim JY; Kim JG; Yoon YH
Retina; 2014 Jan; 34(1):149-56. PubMed ID: 23807186
[TBL] [Abstract][Full Text] [Related]
17. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
[TBL] [Abstract][Full Text] [Related]
19. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
Wang QW; Yao K; Xu W; Chen PQ; Shentu XC; Xie X; Weng Y; Zhang L; Jin CF; Wu W; Zhu YN; Yu YH
Ophthalmologica; 2013; 229(4):187-94. PubMed ID: 23429038
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
Paccola L; Costa RA; Folgosa MS; Barbosa JC; Scott IU; Jorge R
Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
